Relevant bibliographies by topics / Women's cancers

Academic literature on the topic 'Women's cancers'

Author: Grafiati
Published: 25 August 2023

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Contents

Consult the lists of relevant articles, books, theses, conference reports, and other scholarly sources on the topic 'Women's cancers.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Journal articles on the topic "Women's cancers"

1

Johnston, Carolyn. "Focusing on women's cancers." Lancet 349, no. 9052 (March 1997): 658–59. http://dx.doi.org/10.1016/s0140-6736(05)61620-0.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Silva, Catarina, Rosa Perestrelo, Pedro Silva, Filipa Capelinha, Helena Tomás, and José S. Câmara. "Volatomic pattern of breast cancer and cancer-free tissues as a powerful strategy to identify potential biomarkers." Analyst 144, no. 14 (2019): 4153–61. http://dx.doi.org/10.1039/c9an00263d.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

The Lancet. "Keeping watch on women's cancers." Lancet 385, no. 9980 (May 2015): 1804. http://dx.doi.org/10.1016/s0140-6736(15)60911-4.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Fearon, Abbie E., Charlotte R. Gould, and Richard P. Grose. "FGFR signalling in women's cancers." International Journal of Biochemistry & Cell Biology 45, no. 12 (December 2013): 2832–42. http://dx.doi.org/10.1016/j.biocel.2013.09.017.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Frank, Thomas S., and Gregory C. Critchfield. "Hereditary risk of women's cancers." Best Practice & Research Clinical Obstetrics & Gynaecology 16, no. 5 (October 2002): 703–13. http://dx.doi.org/10.1053/beog.2002.0313.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Antone, Nicoleta, Darya Kizub, Julie Gralow, Jo Anne Zujewski, and Allison Dvaladze. "Identifying Facilitators and Barriers to Patient Advocacy for Women's Cancers: Findings from Eastern Europe/Central Asia WE CAN Summits." Journal of Global Oncology 4, Supplement 3 (October 2018): 3s. http://dx.doi.org/10.1200/jgo.18.10010.

Full text
Abstract:
Purpose Patient advocacy plays an important role in alerting policymakers to the public’s concerns about women's cancers and advancing cancer awareness, early diagnosis and care in high-income countries. Patient advocacy for women's cancers is growing in low- and middle-income countries (LMICs) but remains less developed and understudied. This study aimed to describe facilitators and barriers to advocacy from the point of view of advocates for women's cancers participating in Eastern Europe/Central Asia Women's Empowerment Cancer Advocacy Network (WE CAN) Summits. Methods We conducted semistructured, in-depth interviews and focus group discussions with participants representing cancer advocacy organizations from 14 countries attending the 7th Eastern Europe and Central Asia Women’s Empowerment Cancer Advocacy Network (WE CAN) Breast and Cervical Cancer Advocacy Summit held in Romania in 2015. Discussions and interviews were recorded and transcriptions were coded and analyzed. Findings were presented and discussed at the 8th WE CAN EE/CA Summit in Ukraine in 2017. Results Nine in-depth interviews and three focus groups with a total of 36 participants were conducted. Challenges to advocacy included limited collaboration with the medical community, government, and local authorities; a lack of trust between survivors, physicians, and policymakers; difficulty in adapting existing early diagnosis and treatment recommendations to local context and resources; limited organizational professionalism and program monitoring; societal stigma toward cancer; and limited funding. Key facilitators included highly committed staff and volunteers, effective collaboration, and use of social media for networking and to obtain clinical information. Conclusion Our findings highlight the challenges and facilitators of patient advocacy in the Eastern Europe/Central Asia region, involving patient support groups, advocacy organizations, health care systems, policymaking, and societal attitudes and cancer awareness. To advance patient advocacy for women's cancers in the region, the following needs were identified: the dissemination of resourceadapted information for improving patient outcomes, improved program monitoring, and improved dialogue between survivors, medical professionals, and local governments. AUTHORS' DISCLOSURES OF POTENTIAL CONFLICTS OF INTEREST The following represents disclosure information provided by authors of this manuscript. All relationships are considered compensated. Relationships are self-held unless noted. I = Immediate Family Member, Inst = My Institution. Relationships may not relate to the subject matter of this manuscript. For more information about ASCO's conflict of interest policy, please refer to www.asco.org/rwc or ascopubs.org/jco/site/ifc . Julie Gralow Consulting or Advisory Role: Puma, Novartis, Genentech/Roche, Pfizer, Merck, Sandoz, Astra Zeneca, Immunomedics Darya Kizub Employment: Everett Clinic Jo Anne Zujewski Employment: Leidos (part time as an independent contractor for Leidos in support of NCI Center for Global Health) Consulting or Advisory Role: performed consulting services for PMK biomedical and BeyondSpring Pharmaceutical
APA, Harvard, Vancouver, ISO, and other styles
7

Tse, Dan. "Abstract 4154: mRNA-based immunotherapies to treat women's cancers." Cancer Research 83, no. 7_Supplement (April 4, 2023): 4154. http://dx.doi.org/10.1158/1538-7445.am2023-4154.

Full text
Abstract:
Abstract With its ability to potentially code for any given protein, peptide and fragments, synthetic mRNA has landed itself a broad range of cancer immunotherapy applications, including costimulatory receptors, therapeutic antibodies, vaccines, and cytokines able to change the tumor microenvironment.We have been able to leverage our mRNA platform to generate a vaccine for HPV-associated cervical cancer (CC), as well as an immune-stimulatory cytokine for triple negative breast cancer (TNBC), both diseases that disproportionately affects minorities who do not participate in routine medical screenings and contribute to disparity in mortality beyond individual risk factors.IL-12 is a potent pro-inflammatory type 1 cytokine with potential to enter the clinical practice as immunotherapy for cancer. Its use in the form of recombinant protein and/or DNA plasmid has been hampered by issues with systemic toxicity or protein bioavailability within the tumor. To overcome these roadblocks, we developed a novel secreted single chain IL-12p70 mRNA. Intra-tumoral dosing of this mRNA induced tumor regression in a syngeneic and orthotopic mouse model of TNBC. Almost all cervical cancers are HPV (human papilloma virus) associated. We have developed a therapeutic vaccine, based on a single mRNA coding for two de-risked antigens, that is able to induce a T cell response against the oncogenic proteins E6 and E7 of the most common serotype (HPV16). When injected intramuscularly in mice bearing C3.43 masses, this vaccine suppressed tumor growth and generated immunological memory.Currently, these women’s cancers do not have a cure or an effective standard of care. With an efficacy that relies on a few injections and non-invasive routes of administration, we believe our innovative RNA-based pharmaceuticals might close some treatment gaps. Citation Format: Dan Tse. mRNA-based immunotherapies to treat women's cancers. [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2023; Part 1 (Regular and Invited Abstracts); 2023 Apr 14-19; Orlando, FL. Philadelphia (PA): AACR; Cancer Res 2023;83(7_Suppl):Abstract nr 4154.
APA, Harvard, Vancouver, ISO, and other styles
8

Marlow, L. A. V. "Women's understanding of gynaecological cancers and gynaecological cancer screening." Journal of Family Planning and Reproductive Health Care 37, no. 4 (September 16, 2011): 256. http://dx.doi.org/10.1136/jfprhc-2011-100157.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Eaton, S. Boyd, Malcolm C. Pike, Roger V. Short, Nancy C. Lee, James Trussell, Robert A. Hatcher, James W. Wood, et al. "Women's Reproductive Cancers in Evolutionary Context." Quarterly Review of Biology 69, no. 3 (September 1994): 353–67. http://dx.doi.org/10.1086/418650.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Fackelmann, K. A. "Male Cancers Raise Women's Breast Risks." Science News 142, no. 6 (August 8, 1992): 85. http://dx.doi.org/10.2307/3976741.

Full text
APA, Harvard, Vancouver, ISO, and other styles
More sources

Dissertations / Theses on the topic "Women's cancers"

1

Leung, Lisa. "Occupational exposures and cancers in women." Electronic Thesis or Diss., université Paris-Saclay, 2023. http://www.theses.fr/2023UPASR014.

Full text
Abstract:
Contexte : Des résultats issus d'études sur les migrants suggèrent que les facteurs de risque environnementaux peuvent jouer un rôle dans la pathogenèse du cancer du sein, de l'ovaire et du poumon. Néanmoins, l'étiologie de ces cancers reste mal comprise. Bien que les femmes représentent une proportion importante de la main-d'œuvre mondiale, la recherche sur les dangers professionnels auxquels sont exposées les travailleuses demeure limitée. Peu d'études ont examiné les professions fréquentes chez les femmes et les risques professionnels liés aux cancers féminins.Objectifs : Etudier les associations entre 1) la profession, les expositions professionnelles et le cancer de l'ovaire, 2) les expositions professionnelles et le cancer du sein, 3) la profession, les expositions professionnelles et le cancer du poumon.Méthodes : Les données de trois études cas-témoins réalisées dans des populations générales de femmes au Canada et en France, qui recueillaient des informations sur l'historique professionnel, ont été utilisées: l'étude PROVAQ sur le cancer de l'ovaire (491 cas, 897 témoins), l'étude CECILE sur le cancer du sein (1 206 cas, 1 294 témoins) et l'étude WELCA sur le cancer du poumon (731 cas, 751 témoins). Dans ces trois études, un hygiéniste industriel a codé la profession de chaque emploi de chaque participante. Les codes de profession ont été liés à la matrice emplois-expositions canadienne, permettant ainsi de générer des estimations d'exposition pour de nombreux agents. La relation entre l'exposition à chacun des agents les plus répandus et le risque de cancer a été évaluée : 29 agents pour le cancer de l'ovaire, 49 agents pour le cancer du sein et 41 agents pour le cancer du poumon. Pour les cancers de l'ovaire et du poumon, les professions fréquemment rencontrées ont également été examinées. Les associations avec le risque de cancer pour les professions et les expositions professionnelles ont été estimées à l'aide de la régression logistique et en ajustant pour des facteurs de confusion, identifiés à l'aide de graphes acycliques dirigés.Résultats : Des risques accrus de cancer de l'ovaire ont été suggérés pour les professions dans le domaine de la comptabilité, de la vente, de la coiffure et de la couture, ainsi que pour l'exposition professionnelle à des agents liés aux professions de la coiffure. Pour le cancer du sein, l'exposition professionnelle à des agents, en particulier les poussières de fibres textiles, les solvants organiques, les hydrocarbures aromatiques polycycliques, les poussières de plastique et les fumées de pyrolyse, était potentiellement associée à des risques accrus. Il a été suggéré que les risques relatifs diffèrent entre les sous-types de cancer du sein et en fonction du statut ménopausique pour certains agents. Pour le cancer du poumon, des odds ratios élevés ont été observés pour l'enseignement, les professions libérales, les cols-blancs, la vente et les services, ainsi que pour de nombreuses expositions professionnelles, dont certaines étaient cohérentes avec des études antérieures chez les femmes, telles que les fumées de cuisson, le formaldéhyde, les solvants organiques, les hydrocarbures aromatiques polycycliques, les métaux et les peintures/vernis. Les risques de cancer du poumon pour certains agents semblent différer selon le statut tabagique.Conclusions : Certaines professions et expositions professionnelles peuvent être associées à des risques accrus de cancer de l'ovaire, du sein et du poumon chez les femmes. Étant donné que de nombreux résultats étaient imprécis, il est nécessaire de mener d'autres recherches sur des populations générales de femmes afin de reproduire ces résultats. Des études portant sur des échantillons plus importants et l'obtention d'informations provenant de l'évaluation par des experts, permettant d'utiliser des méthodes statiques avancées, peuvent être utiles pour distinguer entre les effets des agents corrélés dans l'estimation du risque de cancer
Background: Evidence from migrant studies suggests that environmental risk factors may play a role in the pathogenesis of breast, ovarian, and lung cancers, yet the etiology of these cancers remains poorly understood. Women account for a significant proportion of the labour force worldwide, yet research on occupational hazards of female workers is limited. Few studies have examined occupations common to women and occupational risks in relation to female cancers.Objectives: The specific objectives of the thesis were: 1) to study the association between occupation, occupational exposures and ovarian cancer, 2) to study the association between occupational exposures and breast cancer, and 3) to study the association between occupation, occupational exposures and lung cancer in women.Methods: Data from three population-based case-control studies on women in Canada and France that collected occupational history information was used to achieve the objectives: the PROVAQ study on ovarian cancer (491 cases, 897 controls), the CECILE study on breast cancer (1,206 cases, 1,294 controls), and the WELCA study on lung cancer (731 cases, 751 controls). In all three studies, an industrial hygienist coded the occupation of each participant's job. Job codes were linked to the Canadian job-exposure matrix, thereby generating exposure estimates for many agents. The relationship between exposure to each of the most prevalent agents and cancer risk was assessed, specifically 29 agents for ovarian cancer, 49 agents for breast cancer, and 41 agents for lung cancer. For ovarian and lung cancers, prevalent occupations were additionally examined by comparing participants employed in an occupation for <10 years and ≥10 years vs. never employed in the occupation. Associations with cancer risk for occupations and occupational exposures were estimated using logistic regression and adjusting for minimally sufficient confounder sets, identified using directed acyclic graphs.Results: Excess ovarian cancer risks were suggested for accountancy, sales, hairdressing, and sewing occupations, and for occupational exposure to agents linked to hairdressing-related occupations. Interpretations of results for single agents were limited due to multiple correlated exposures. For breast cancer, occupational exposure to agents, particularly textile fibre dusts, organic solvents, polycyclic aromatic hydrocarbons, plastic dusts and pyrolysis fumes, were potentially associated with increased risks. Relative risks were suggested to differ among breast cancer subtypes and according to menopausal status for some agents. For lung cancer, elevated odds ratios were observed for teaching, professional, white-collar, sales, and service occupations, and for numerous occupational exposures, some of which were consistent with previous studies in women, such as cooking fumes, formaldehyde, organic solvents, polycyclic aromatic hydrocarbons, metals, and paints/varnishes. Lung cancer risks for some agents were suggested to differ by smoking status.Conclusions: Certain occupations and occupational exposures may be associated with excess ovarian, breast, and lung cancer risks in women. As many odds ratios observed were imprecise, further population-based research on women is warranted to replicate findings. Studies with larger sample sizes and expert assessment information that can perform more advanced statistical methods accounting for multiple exposures may be useful in disentangling the effects of correlated agents in the estimation of cancer risk
APA, Harvard, Vancouver, ISO, and other styles
2

Moberg, Kerstin. "Incidence and interval breast cancers in retrospective assessment /." Stockholm, 2003. http://diss.kib.ki.se/2003/91-7349-573-5.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Li, Li. "Antitumor Activities of 2-Methoxyestradiol on Cervical and Endometrial Cancers In Vitro and In Vivo." Doctoral thesis, Uppsala : Acta Universitatis Upsaliensis : Univ.-bibl. [distributör], 2004. http://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-4554.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Vuillermoz, Cécile. "Conditions de vie, état de santé et recours aux soins des femmes sans logement personnel hébergées en Ile-de-France." Thesis, Paris 6, 2017. http://www.theses.fr/2017PA066108/document.

Full text
Abstract:
Un corpus de recherches en sciences sociales et en santé publique menées principalement en Amérique du Nord depuis les années 1980 montre que l'absence de logement personnel a un effet délétère sur l'état de santé, physique et psychique des familles sans logement. En France, les études quantitatives sur la santé des femmes sans-domicile restaient exceptionnelles avant la réalisation de l'enquête ENFAMS conduite en Ile-de-France en 2013. A partir des données de cette enquête, nous avons montré que, bien qu’elles soient plus jeunes que les femmes en population générale, la santé des femmes sans logement est plus mauvaise, en particulier en ce qui concerne leur santé mentale et leur santé nutritionnelle. Malgré un état de santé plus mauvais, les femmes sans logement ont moins recours aux soins que les femmes en population générale. Cette thèse a permis de souligner l’importance du suivi gynécologique dans l’accès au dépistage des cancers féminins puisque la proportion de femmes dépistées du cancer du col de l’utérus est deux fois plus élevée chez les femmes avec un suivi que chez celles sans suivi. Nous avons aussi montré que dans le contexte français d’une couverture maladie universelle et de l’existence de filets de protection sociale, nous ne retrouvons pas les associations classiquement observées entre renoncement aux soins et ressources financières ou assurance maladie. Les professionnels en soins primaires doivent s’appuyer sur les fenêtres d’opportunité de dépistage qu’offre chacun de leur contact avec les services de soins. Les stratégies d’amélioration à l’accès aux soins de ces femmes ne doivent pas seulement viser à lever les obstacles financiers
Social sciences and public health research conducted mainly in North America, since the 1980s, have shown that homelessness has a significant impact on health, physical conditions and psychological health of families without housing. In France, quantitative studies on homeless women were scarce until the realization of the ENFAMS survey in Paris region in 2013.Based on data from this survey, we showed that, although younger than women in the general population, the health of homeless women is worse, especially with regards to their mental health and nutritional status. Despite their poor health, homeless women have less access to health care than women in the general population. Our research has highlighted the importance of gynecological follow-up in accessing women's cancer screening since the proportion of women who were screened for cervical cancer was twice as high among women with follow-up than among women without follow-up. We have also shown that in the French context of universal health coverage and numerous social safety nets, we do not find the classic associations between unmet health care needs and financial resources or health insurance status.Primary care professionals need to rely on windows of opportunity provided by each of their contact with health care services to make them benefit from cancer screening. Strategies to improve the access to health care of these women must not only aim to remove financial barriers
APA, Harvard, Vancouver, ISO, and other styles
5

Chan, Suk-fong Cecilia. "Coping and adaptation : women with breast cancer /." [Hong Kong : University of Hong Kong], 1985. http://sunzi.lib.hku.hk/hkuto/record.jsp?B12322325.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Ling, Bih-yu Anne. "An exploration into the problems and adjustment of gynaecological cancer patients in Hong Kong, with implications for social work practice /." [Hong Kong : University of Hong Kong], 1986. http://sunzi.lib.hku.hk/hkuto/record.jsp?B12325855.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Bancroft, Kelly A. "Boob Suit: Tales of the Dressed Flesh." Youngstown State University / OhioLINK, 2012. http://rave.ohiolink.edu/etdc/view?acc_num=ysu1335401944.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Swainston, Katherine. "Women's experiences of breast cancer : a longitudinal perspective." Thesis, Teesside University, 2013. http://hdl.handle.net/10149/301650.

Full text
Abstract:
Utilising a hermeneutic phenomenological approach twenty women’s experiences of breast cancer were explored through semi-structured interviews at three time points during their healthcare trajectory from recent diagnosis to early follow-up. Phenomenological analysis guided by van Manen’s (1990) principles revealed numerous multifaceted themes some of which were time limited while others spanned the data collection period. Use was made of an adapted life grid approach in order to enhance the implicit meanings to be elicited through interpretation of text. Central themes depicting the medicalisation of breast cancer, perceptions and management of the body and participants’ emotional journey were uncovered. Breast cancer was found to represent a biographical disruption that had a long-term impact on a woman’s body, self, identity and sense of embodiment. Changes to the body, due to breast cancer treatment, and an altered way of being in the world, elicited disruption to the body-self relationship, a separation that was reinforced by the healthcare system. Participants were found to adopt a variety of coping strategies to manage ongoing change and the stress elicited by experiencing breast cancer as a chronic illness. Avoidance, information management, conscious passivity in treatment decision-making and positive cognitive restructuring are examples of such mechanisms. However, women’s experiences of each theme identified and the emergence and maintenance of these themes varied according to women’s biography, diagnosis and prescribed treatment regime, cancer schema, and social support. Accordingly, models of care must address women’s individual experiences and recognise their changing needs throughout the year post diagnosis.
APA, Harvard, Vancouver, ISO, and other styles
9

Tetteh, Dinah A. "Stories of Teal: Women's Experiences of Ovarian Cancer." Bowling Green State University / OhioLINK, 2016. http://rave.ohiolink.edu/etdc/view?acc_num=bgsu1463061941.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

McNamara, Nancy Taylor 1961. "Older healthy Hispanic women's beliefs about breast cancer." Thesis, The University of Arizona, 1992. http://hdl.handle.net/10150/278170.

Full text
Abstract:
An exploratory descriptive design was used to investigate older healthy Hispanic women's beliefs about breast cancer. A secondary analysis of a database from a larger study dealing with Hispanic and Anglo women's knowledge of breast cancer and use of breast cancer screening was conducted. Using Orem's theory of self-care and self-care deficit as the framework, and content analysis, data were obtained from a two part question of the original 63 item questionnaire. A major finding was that hopelessness/powerlessness received the largest number of responses, especially from the youngest subjects, 50 to 69 years old. The seventy year olds had the largest number of responses in the acceptance category, while the eighty year olds had the largest in the denial category. The results supported the importance of culturally relevant and sensitive nursing practice. Reasons for older healthy Hispanic women's beliefs about breast cancer are discussed as well as recommendations for nursing practice and future research.
APA, Harvard, Vancouver, ISO, and other styles
More sources

Books on the topic "Women's cancers"

1

Keen, Alison, and Elaine Lennan, eds. Women's Cancers. West Sussex, UK: John Wiley & Sons, Ltd., 2011. http://dx.doi.org/10.1002/9781118786635.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Women's cancers. Chichester, West Sussex, UK: Wiley-Blackwell, 2011.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
3

Suzanne, Lockwood, ed. Contemporary issues in women's cancers. Sudbury, Mass: Jones and Bartlett Publishers, 2009.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
4

Giuseppe, Del Priore, ed. Women's cancers: Pathways to living. Hackensack, NJ: Imperial College Press, 2015.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
5

Cady, Blake, and Cornelius O. Granai. Cancers unique to women. Philadelphia: W.B. Saunders, 1998.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
6

C, Hartmann Lynn, Loprinzi Charles L, and Gostout Bobbie S, eds. Mayo Clinic guide to women's cancers. Rochester, Minn: Mayo Clinic, 2005.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
7

Dawson, Donna. Women's cancers: The treatment options : everything you need to know. [London]: Piatkus, 1990.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
8

Smith, J. Richard. Women's cancers: Pathways to healing : a patient's guide to dealing with cancer and abnormal smears. London: Springer, 2009.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
9

Smith, J. Richard. Women's cancers: Pathways to healing : a patient's guide to dealing with cancer and abnormal smears. London: Springer, 2009.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
10

L, Scott Jennifer, ed. Helping couples cope with women's cancers: An evidence-based approach for practitioners. New York: Springer, 2008.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
More sources

Book chapters on the topic "Women's cancers"

1

Harmer, Victoria, and Maureen Royston-Lee. "The History of Women in Relation to Health and Cancer." In Women's Cancers, 1–8. West Sussex, UK: John Wiley & Sons, Ltd., 2013. http://dx.doi.org/10.1002/9781118786635.ch1.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Metcalf, Ken, and Katherine McCarthy. "Cancer of the Cervix." In Women's Cancers, 142–56. West Sussex, UK: John Wiley & Sons, Ltd., 2013. http://dx.doi.org/10.1002/9781118786635.ch10.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Bull, Ellen, and Robert Woolas. "Cancer of the Endometrium." In Women's Cancers, 157–71. West Sussex, UK: John Wiley & Sons, Ltd., 2013. http://dx.doi.org/10.1002/9781118786635.ch11.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Tinkler, Sandra. "Cancer of the Vagina." In Women's Cancers, 172–82. West Sussex, UK: John Wiley & Sons, Ltd., 2013. http://dx.doi.org/10.1002/9781118786635.ch12.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Isaac, Beccy Hoddinott, and Lisa Young. "Cancer of the Vulva." In Women's Cancers, 183–98. West Sussex, UK: John Wiley & Sons, Ltd., 2013. http://dx.doi.org/10.1002/9781118786635.ch13.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Ingamells, Susan, C. Basu, J. Tucker, and A. Umranikar. "Fertility and Cancer in Women." In Women's Cancers, 199–215. West Sussex, UK: John Wiley & Sons, Ltd., 2013. http://dx.doi.org/10.1002/9781118786635.ch14.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Donelly-Cairns, Karen. "Sexual Health and Dysfunction." In Women's Cancers, 216–29. West Sussex, UK: John Wiley & Sons, Ltd., 2013. http://dx.doi.org/10.1002/9781118786635.ch15.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Keen, Alison. "Women and Cancer: Rehabilitation and Survivorship." In Women's Cancers, 230–38. West Sussex, UK: John Wiley & Sons, Ltd., 2013. http://dx.doi.org/10.1002/9781118786635.ch16.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Grant, Jane, and Carol L. Davis. "Palliative Care." In Women's Cancers, 239–61. West Sussex, UK: John Wiley & Sons, Ltd., 2013. http://dx.doi.org/10.1002/9781118786635.ch17.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Gordon, Louisa G., Christina M. Nagle, and Penelope M. Webb. "The Epidemiology of Women's Cancers." In Women's Cancers, 9–31. West Sussex, UK: John Wiley & Sons, Ltd., 2013. http://dx.doi.org/10.1002/9781118786635.ch2.

Full text
APA, Harvard, Vancouver, ISO, and other styles

Conference papers on the topic "Women's cancers"

1

Lee, Jung-Min, Alyssa Stacy, Minshu Yu, and Elise C. Kohn. "Abstract A249: Navitoclax and veliparib yield cytotoxicity with lower doses than used for single agents in women's cancers." In Abstracts: AACR-NCI-EORTC International Conference: Molecular Targets and Cancer Therapeutics--Oct 19-23, 2013; Boston, MA. American Association for Cancer Research, 2013. http://dx.doi.org/10.1158/1535-7163.targ-13-a249.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Labrie, Marilyne, Zhenlin Ju, Jennifer K. Litton, Tae-Beom Kim, Sanghoon Lee, Ken Chen, Pamela T. Soliman, et al. "Abstract 2070: Exploration of markers of synergistic lethality of PARP and PI3K-Akt-mTOR inhibitors in women's cancers." In Proceedings: AACR Annual Meeting 2019; March 29-April 3, 2019; Atlanta, GA. American Association for Cancer Research, 2019. http://dx.doi.org/10.1158/1538-7445.sabcs18-2070.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Labrie, Marilyne, Zhenlin Ju, Jennifer K. Litton, Tae-Beom Kim, Sanghoon Lee, Ken Chen, Pamela T. Soliman, et al. "Abstract 2070: Exploration of markers of synergistic lethality of PARP and PI3K-Akt-mTOR inhibitors in women's cancers." In Proceedings: AACR Annual Meeting 2019; March 29-April 3, 2019; Atlanta, GA. American Association for Cancer Research, 2019. http://dx.doi.org/10.1158/1538-7445.am2019-2070.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Knaul, FM. "Abstract IS-1: Health System Responses to Women's Cancers in the Americas: Closing Divides to Achieve Universal Health Coverage." In Abstracts: 2017 San Antonio Breast Cancer Symposium; December 5-9, 2017; San Antonio, Texas. American Association for Cancer Research, 2018. http://dx.doi.org/10.1158/1538-7445.sabcs17-is-1.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Chiou, Victoria L., Christina Annunziata, Stanley Lipkowitz, Lori Minasian, Nicolas Gordon, Minshu Yu, Seth Steinberg, Nicole Houston, Elise Kohn, and Jung-min Lee. "Abstract CT326: Pharmacokinetic/pharmacodynamic study of sequence specificity of the PARP inhibitor, olaparib and carboplatin in recurrent women's cancers." In Proceedings: AACR 106th Annual Meeting 2015; April 18-22, 2015; Philadelphia, PA. American Association for Cancer Research, 2015. http://dx.doi.org/10.1158/1538-7445.am2015-ct326.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Bruckner, Howard W., Azriel Hirschfeld, Jeanetta Stega, and Peter Dottino. "Abstract CT314: “Multi-metronomic” algorithms for targeted therapy to improve value of response and “failed drugs” for “resistant” women's cancers." In Proceedings: AACR Annual Meeting 2014; April 5-9, 2014; San Diego, CA. American Association for Cancer Research, 2014. http://dx.doi.org/10.1158/1538-7445.am2014-ct314.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Goey, Andrew K. L., Cody J. Peer, Tristan M. Sissung, Jeffrey Roth, Shandiz Shahbazi, Jeffers Nguyen, Christina M. Annunziata, et al. "Abstract 2043: Effects of 24-h carboplatin pretreatment on olaparib clearance in women's cancers using noncompartmental and population pharmacokinetic analyses." In Proceedings: AACR 107th Annual Meeting 2016; April 16-20, 2016; New Orleans, LA. American Association for Cancer Research, 2016. http://dx.doi.org/10.1158/1538-7445.am2016-2043.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Lee, Jung-min, John Hays, Christina M. Annunziata, Lori Minasian, JoAnne Zujewski, Jennifer Squires, Deborah Nielsen, et al. "Abstract 1754: A pharmacokinetics/pharmacodynamics study of sequence specificity of the PARP inhibitor, olaparib (O) with carboplatin (C) in recurrent women's cancers NCT01237067." In Proceedings: AACR 103rd Annual Meeting 2012‐‐ Mar 31‐Apr 4, 2012; Chicago, IL. American Association for Cancer Research, 2012. http://dx.doi.org/10.1158/1538-7445.am2012-1754.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Herman, B. "APPLICATIONS OF LASER OPTICAL MICROSCOPIC TECHNIQUES IN DECIPHERING DISEASE SPECIFIC MECHANISMS AND DIAGNOSIS." In Biomedical Optical Spectroscopy and Diagnostics. Washington, D.C.: Optica Publishing Group, 2006. http://dx.doi.org/10.1364/bosd.1996.ft5.

Full text
Abstract:
Accumulating evidence strongly associates human papillomavirus infection with the development of cervical cancers. However, it has also become increasingly clear that HPV infections of the cervix span a wide clinical spectrum from benign lesions to precancerous lesions, with only a minority of infections resulting in invasive cancers, although the reasons for this are not clear. Longitudinal epidemiologic studies using cytologic methods to detect HPV infection have shown that the majority of women infected with HPV will regress spontaneously. In addition, age-stratified data for rates of HPV positivity from cross-sectional studies also suggest that many women clear the infection spontaneously. These results support the concept that many women may be only transiently infected with HPV during their life span and only in women with persistent HPV infection does cervical cancer progress. In addition to persistence of HPV infection, recent epidemiological studies indicate that the amount of high-risk HPV (viral load or HPV gene copy number) in cervicovaginal epithelial cells may be a risk factor for cervical cancer. Thus, a technique which could detect, genotype and quantitate HPV in smears of cervicovaginal epithelial cells would be of major import in assessment of patient clinical status as well as in epidemiological studies relating HPV infection to cervical cancer.
APA, Harvard, Vancouver, ISO, and other styles
10

Ferreira, Guilherme Ribeiro, Bianca Dias Socci, Héctor Hugo Queiroz Francto, Yasmin Arroyo de Moraes, and João Lucas de Moraes. "Breast cancer mortality in Brazil between the years 2000 and 2020: ecological study." In II INTERNATIONAL SEVEN MULTIDISCIPLINARY CONGRESS. Seven Congress, 2023. http://dx.doi.org/10.56238/homeinternationalanais-026.

Full text
Abstract:
Abstract Breast cancer is one of the most incident cancers and has been considered the leading cause of death for women worldwide. When it is restricted to a mumlobulum or duct it is defined as noninvasive breast cancer, such as ductal carcinoma in situ and lobular carcinoma in situ. On the other hand, when malignant cells extend to regions adjacent to or far from breast tissue, an invasive or metastatic breast cancer is characterized, such as infiltrated ductal and lobular carcinomas, mucinous carcinoma, and tubular carcinoma.
APA, Harvard, Vancouver, ISO, and other styles

Reports on the topic "Women's cancers"

1

Wang, Ying yuan, Zechang Chen, Luxin Zhang, Shuangyi Chen, Zhuomiao Ye, Tingting Xu, and Yingying Zhang c. A systematic review and network meta-analysis: Role of SNPs in predicting breast carcinoma risk. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, February 2022. http://dx.doi.org/10.37766/inplasy2022.2.0092.

Full text
Abstract:
Review question / Objective: P: Breast cancer patient; I: Single nucleotide polymorphisms associated with breast cancer risk; C: Healthy person; O: By comparing the proportion of SNP mutations in the tumor group and the control group, the effect of BREAST cancer risk-related SNP was investigated; S: Case-control study. Condition being studied: Breast cancer (BC) is one of the most common cancers among women, and its morbidity and mortality have continued to increase worldwide in recent years, reflecting the strong invasiveness and metastasis characteristics of this cancer. BC is a complex disease that involves a sequence of genetic, epigenetic, and phenotypic changes. Polymorphisms of genes involved in multiple biological pathways have been identified as potential risks of BC. These genetic polymorphisms further lead to differences in disease susceptibility and severity among individuals. The development of accurate molecular diagnoses and biological indicators of prognosis are crucial for individualized and precise treatment of BC patients.
APA, Harvard, Vancouver, ISO, and other styles
2

Venedicto, Melissa, and Cheng-Yu Lai. Facilitated Release of Doxorubicin from Biodegradable Mesoporous Silica Nanoparticles. Florida International University, October 2021. http://dx.doi.org/10.25148/mmeurs.009774.

Full text
Abstract:
Cervical cancer is one of the most common causes of cancer death for women in the United States. The current treatment with chemotherapy drugs has significant side effects and may cause harm to healthy cells rather than cancer cells. In order to combat the potential side effects, nanoparticles composed of mesoporous silica were created to house the chemotherapy drug doxorubicin (DOX). The silica network contains the drug, and a pH study was conducted to determine the conditions for the nanoparticle to disperse the drug. The introduction of disulfide bonds within the nanoparticle created a framework to efficiently release 97% of DOX in acidic environments and 40% release in neutral environments. The denotation of acidic versus neutral environments was important as cancer cells are typically acidic. The chemistry was proved with the incubation of the loaded nanoparticle into HeLa cells for a cytotoxicity report and confocal imaging. The use of the framework for the anticancer drug was shown to be effective for the killing of cancerous cells.
APA, Harvard, Vancouver, ISO, and other styles
3

Lewis, Frances M. Factors Affecting African American Women's Participation in Breast Cancer Screening Programs: A Qualitative Study of Uninsured Low Income Women. Fort Belvoir, VA: Defense Technical Information Center, August 2001. http://dx.doi.org/10.21236/ada396858.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Lewis, Frances M. Factors Affecting African American Women's Participation in Breast Cancer Screening Programs: A Qualitative Study of Uninsured Low Income Women. Fort Belvoir, VA: Defense Technical Information Center, August 2004. http://dx.doi.org/10.21236/ada428540.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Lewis, Frances M., Ellen Phillips-Angeles, and Lin Song. Factors Affecting African American Women's Participation in Breast Cancer Screening Programs: A Qualitative Study of Uninsured Low Income Women. Fort Belvoir, VA: Defense Technical Information Center, August 2003. http://dx.doi.org/10.21236/ada418268.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Dodd, Marylin J. Exploring Women's Perceptions of Their Risk of Developing Breast Cancer. Fort Belvoir, VA: Defense Technical Information Center, June 2008. http://dx.doi.org/10.21236/ada493643.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Katapodi, Maria C. Exploring Women's Perceptions of Their Risk of Developing Breast Cancer. Fort Belvoir, VA: Defense Technical Information Center, May 2004. http://dx.doi.org/10.21236/ada427959.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Katapodi, Maria C. Exploring Women's Perceptions of Their Risk of Developing Breast Cancer. Fort Belvoir, VA: Defense Technical Information Center, June 2007. http://dx.doi.org/10.21236/ada472081.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Yelena, Gorina, and Elgaddal Nazik. Patterns of Mammography, Pap Smear, and Colorectal Cancer Screening Services Among Women Aged 45 and Over. National Center for Health Statistics, June 2021. http://dx.doi.org/10.15620/cdc:105533.

Full text
Abstract:
This study examines and compares sociodemographic, health status, and health behavior patterns of screening for breast cancer, cervical cancer, and colorectal cancer among women aged 45 and over in the United States.
APA, Harvard, Vancouver, ISO, and other styles
10

Li, Tong, Erin Mathieu, Michelle Dickson, and Nehmat Houssami. Evidence relevant to early detection of breast cancer in Aboriginal and Torres Strait Islander women. The Sax Institute, August 2021. http://dx.doi.org/10.57022/plnx1508.

Full text
Abstract:
This Evidence Snapshot aims to summarise the current and emerging evidence regarding early detection of breast cancer in Aboriginal and Torres Strait Islander women and its impact on cancer stage at diagnosis and mortality. Gaps were found in the evidence regarding impact, but evidence was found regarding incidence, participation, and mortality. Aboriginal and Torres Strait Islander women over 60 were found to have higher incidence of breast cancer than non-indigenous women, and overall Aboriginal and Torres Strait Islander women were found to have lower screening participation rates. Regarding treatment and outcomes, the included studies varied considerably in terms of treatment, but the evidence showed that Aboriginal and Torres Strait Islander women are approximately twice as likely to die from breast cancer than non-indigenous women.
APA, Harvard, Vancouver, ISO, and other styles
You might also be interested in the extended bibliographies on the topic 'Women's cancers' for particular source types:
Journal articles Dissertations / Theses Books
We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!

To the bibliography